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ESTROGEN INDUCED EOSINOPIDL MIGRATION INTO THE AUGUST RAT
UTERUS IS ASSOCIATED WITH INTERCELLULAR ADHESION
MOLECULE EXPRESSION
Daniel R. Orcutt, M. S.
Western Michigan University, 1994
Estrogen causes an influx of eosinophils into the uterus in female rats. The
diapedesis of eosinophils out of the vasculature has also been observed in allergic
reactions, parasitic infections, and atopic dermatitis, and has been associated with
cellular adhesion molecules (CAMs). Antibody blocking studies against ICAM-1/
LFA-1 and VCAM-lNLA-4 have suggested that both ligand/receptor sets of CAMs
are involved in the selective recruitment of eosinophils out of the vasculature. ICAM1 is expressed on the vascular endothelium and decreases in expression when IL-4 is
introduced. VLA-4 is present on eosinophils and is suspected to allow selective
migration of eosinophils out of the blood system. Uterii of immature rats treated with
either diethylstilbesterol (DES) or vehicle, were labeled with monoclonal antibodies
against ICAM-1 and VLA-4. ICAM-1 expression decreased in DES treated animals
and VLA-4 expression was up regulated on eosinophils within the uterus. Estrogens
may signal eosinophils to increase VLA-4 expression while signaling uterine
vasculature to decrease ICAM-1 expression, enabling selective eosinophil migration.
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STATEMENT OF THE PROBLEM
Estrogen is an ovarian hormone secreted in response to a CNS regulated
pattern of follicle stimulating hormone (FSH) secretion. FSH is released from the
adenohyp ophysis during the proestrous phase of the estrus cycle. During proestrus,
plasma estrogen elevates and the uterus goes through many preparative steps for egg
implantation. One of these steps may be the extravasation of eosinophils into uterine
tissues.

If estrogen is injected into an immature or ovariectomized rat, similar

migration of eosinophils can be induced (Bjersing & Borglin, 1963). This study was
designed to try to determine whether changes in two specific cellular adhesion
molecules, ICAM-1 and VLA-4, were associated with migration of the eosinophil
from the blood supply into the uterus during times of elevated blood estrogen. VLA-4
was chosen due to its putative role in selective migration of eosinophils out of the
vasculature. ICAM-1 was selected because of its role in leukocyte migration during
acute inflammation.
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INTRODUCTION
The Eosinophil
The eosinophil is a white blood cell involved in many disease processes and has
been generally associated with allergies and parasitic infections. These cells carry
specific cytosolic granules that contain cationic proteins which have been shown to
damage or destroy their target. Some of these targets include helminths, protozoa,
and bacteria. Apart from challenging foreign organisms eosinophils play a role in
cutaneous diseases. These include; syndromes associated with edema (i.e. Wells
disease), dermatitides (i.e. atopic dermatitis), and syndromes associated with fibrosis
(i.e. Spanish toxic oil syndrome) (Gleich et al., 1992a). It is well documented that the
released granules of the eosinophil cause some of the major symptoms of asthma and
other hypersensitivity diseases (Frigas & Gleich, 1986).
The granules in the cytoplasm of the eosinophil are electron dense and readily
stain with acidic dyes such as eosin, from which the name eosinophil is derived. There
are four major eosinophil granule proteins. The first is major basic protein (MBP),
located in the core of the granule which has an isoelectric point of pH 10. 9 (Gleich et
al., 1992b). This protein is particularly damaging to parasites such as helminths and
protozoa and can kill bacteria and mammalian cells. MBP also stimulates histamine
release from mast cells and basophils and activates neutrophils and platelets (Gleich et
2
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al., 1992b). Eosinophil Cationic Protein (ECP) is a very basic protein also, with an
isoelectric point of pH 10.8. This protein is located in the eosinophil granule matrix
and is a member of the ribonuclease gene superfamily. This gene family includes
Eosinophil Derived Neurotoxin (EON) and pancreatic ribonuclease. ECP is toxic to
bacteria, helminths, protozoa, and mammalian cells. A less toxic granule protein is
found in Eosinophil Derived Neurotoxin (EON). EON only weakly affects parasites
and mammalian cells (Gleich et al., 1992b). This protein is extensively deposited along
with MBP in atopic dermatitis (Leiferman, 1991).

A fourth granule protein is

eosinophil peroxidase (EPO). It is localized in the matrix of the eosinophil granules
and has two mechanisms of toxicity. If there is a peroxide generating system available,
e.g., NADPH oxidase, it oxidizes a halide producing a hypohalus acid.

This

peroxidase activity is very toxic to parasites, bacteria, viruses, microplasma and fungi.
In the absence of a peroxide, EPO is still potent in killing parasites and mammalian
cells via its toxic cationic effects; however, this is probably not its major mechanism
(Gleich et al., 1992b). Another protein is a small constituent in the granules called the
Charcot Leyden Crystal protein (CLC). This protein has a lysophospholipase, activity
but the role that it plays in disease is still undetermined (Gleich et al., 1992a).
Eosinophils also synthesize many different inflammatory mediators. These
mediators signal other immune cells as well as the vascular endothelium. Platelet
activating factor (PAF) is one of these mediators.

PAF causes an increase in

cutaneous vascular permeability, and bronchoconstriction. PAF is also an eosinophil
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chemoattractant (Gleich et al., 1992a).

Leukotriene C4 (LTC4 ) is produced by

eosinophils and causes bronchoconstriction and changes vascular permeability (Gleich
et al., 1992a). Eosinophils also produce other leukotrienes (LT�, LTB4, LTD4, and
LTE4), but the dominant product is LTC4 (Weller, 1991).

Other inflammatory

mediators that eosinophils can produce are; transforming growth factor-alpha (TGF-a)
(Wong et al., 1990), transforming growth factor-beta (TGF-�) (Wong et al., 1991),
interleukin-I (IL-1) (Del Pozo et al., 1990), granulocyte macrophage colony
stimulating factor (GM-CSF) (Moqbel et al., 1991), interleukin-5 (IL-5) (Desreumaux
et al., 1992), and interleukin-3 (IL-3) (Kita et al., 1991). It is not now possible to
describe the secretory response pattern of the eosinophil to specific stimuli. It seems
better to comment that depending on the stimulus, as well as the surrounding cells,
eosinophils may elicit events beyond their effector functions of degranulation,
oxidative burst, and eicosanoid release.
Enhancement in the ability of eosinophils to produce proinflammatory
mediators is caused by many cytokines and inflammatory mediators. Included in these
activators are mononuclear derived factors; IL-5, GM-CSF, IL-3, and tumor necrosis
factor-alpha (TNF-a) (Silberstein et al., 1989). Some other eosinophil activators are
the complement component, C5a (Kernan et al., 1991), and PAF (Kroegel et al.,
1989). Activation also includes an increased ability to bind to endothelium. Adhesion
of eosinophils to endothelium can be increased with PAF, IL-5, IL-3, as well as IL-4
stimulation (Thornhill & Haskard, 1991; Moser et al., 1992a).
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There are many different types of membrane associated molecules on
eosinophils that play functional roles.

They can be divided into three groups;

immunoglobulin and complement receptors, cytokine receptors, and adhesion
molecules.

There are receptors for immunoglobulin G (IgG), immunoglobulin E

(IgE), immunoglobulin A (IgA), and immunoglobulin D (IgD). Complement receptors
include; Clq, C3b/C4b (CRl), C3b (CR3) and C5a (Gleich et al., 1992a).

The

cytokine receptors on eosinophils include IL-5, IL-3, GM-CSF (Chihara et al., 1990),
interferon-gamma (IFN-o), IFN-f3, TNF-a (Valerius et al., 1990), PAF (Kroegel et al.,
1989), and leukotriene B4 (LTB4) (Maghini et al,, 1991). Adhesion molecule classes
that eosinophils possess include those of the immunoglobulin gene superfamily
(Springer, 1990), integrins (Hartnell et al., 1990), and selectins (Fakuda et al., 1984).
Adhesion molecules and eosinophil stimulation are most likely important in eosinophil
migration into the uterus.
Eosinophils possess and can synthesize CD 4 positive molecules as well as
maJor histocompatability complex II.

These transmembrane proteins may allow

eosinophils to interact with CD 4 positive lymphocytes as antigen presenting cells
(Lucey et al., 1989; Weller et al., 1991). The CD 4 positive protein and the major
histocompatability proteins may enable eosinophils to fulfill effector functions
analogous to those found in helper T cells and macrophages.
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Inflammation and Adhesion
When there is inflammation, cytokines released at the site activate circulating
leukocytes, especially neutrophils and monocytes, as well as the nearby endothelium.
The activation of the endothelium causes a change in adhesion receptors on both the
leukocyte and the · endothelium.

These changes in the expression of adhesion

molecules can lead to increased adhesion and extravasation of specific white blood
cells (Resnick & Weller, 1993). These changes may not be limited to up regulation or
down regulation, but may also include conformational or affinity changes (Detmers et
al., 1988), resulting from phosphorylation (Chatila et al., 1989).
When a leukocyte or endothelial cell becomes activated they are more
adhesive, leading to blood cell margination to the post capillary veinule walls
(Springer, 1990). This margination results in loose associations, or the rolling of the
cells along the endothelium. They then adhere firmly to the endothelial wall and
migrate between the junctions of the cells. Adhesion probably plays a very important
role in the activation of these cells as well as their migration into the underlying
tissues. Different cells possess various adhesion molecules and express them in unique
ways, which can allow specific cell immigration.
There are three major families of adhesion molecules involved in leukocyte
migration out of the vasculature. The immunoglobulin gene superfamily is one of
these groups. This family includes intercellular adhesion molecule-I (ICAM-1) and
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intercellular adhesion molecule-2 (ICAM-2). They are both constitutively expressed
on the endothelium, and ICAM-1 can be up regulated by TNFa, IL-I, lymphotoxin,
IFN-5, and lipopolysaccharides (LPS) (Dustin et al., 1986). ICAM-1 and ICAM-2 can
bind to lymphocyte function-associated antigen-I (LFA-1, CDI l a/CD18) (Dobrina et
al., 1991). ICAM-1 is also present on the eosinophil's surface and can be up regulated
by IFN-5, TNF-a, and IL-3 (Czech, 1993). Vascular cell adhesion molecule-I
(VCAM-1) is also in this supergene family and is only minimally expressed on
unstimulated endothelial cells (Schleimer et al., 1992). IL-5, IL-4, TNF-a, and LPS
cause the synthesis and expression of VCAM-1 (Dobrina et al., 1991). IL-4 seems to
uniquely up regulate VCAM-1 on the endothelium (Thornhill & Haskard, 1991).
The second family of CAMs is the integrin family made up of heterodimers
with one alpha and one beta subunit. There are at least 11 different alpha subunits and
7 different beta subunits (Walsh et al., 1993). P2 integrins are limited to white blood
cells and include LFA-1, CR3, and plS0,95.
leukocytes (Krensky et al., 1983).

LFA-1 is widely expressed on all

CR3 is a receptor for the third component of

complement cascade, and is up regulated by exposure to IL-5, IL-3, GM-CSF, and
PAF (Lopez et al., 1988; Walsh et al., 1990). PlS0,95 is a necessary ligand for the
adhesion ofmonocytes and neutrophils to endothelial cells (Lo et al., 1989).
The p 1 integrins are mainly receptors for extracellular matrix proteins. VLA-4
is a unique p 1 integrin because it is influential in cell-cell interactions (Helmer, 1990).
VLA-4 is constitutively expressed on eosinophils and is not expressed on neutrophils

8
(Walsh et al., 1993). VLA-4 selectively binds to VCAM-1 (Anderson & Springer,
1987). Increase in expression of VLA-4 in blood lymphocytes has been seen m
patients with systemic lupus erythematosus (SLE) (Takeuchi et al., 1993).
The third major family of adhesion molecules are the selectins.

These

molecules are prominent in lymphocyte and eosinophil interactions with vascular
endothelium. Endothelial-leukocyte adhesion molecule-I (ELAM-I, E-Selectin) is not
constitutively expressed on the endothelium but can be induced by IL-1, LPS, and
TNF-a. (Bevilacqua et al., 1987). ELAM-1 is a lectin recognizing various forms of the
Lewis X glycans (Kyan-Aung et al., 1991). L-selectins contribute to neutrophil
emigration at inflammatory sites (Jutila et al., 1989). They are involved in the initial
adherence, binding to sialoglycoproteins (Smith et al., 1992). P-selectin is transiently
and rapidly translocated to the cell surface in response to inflammatory stimuli such as
histamine or thrombin (Hottori et al., 1989). ELAM-1, L-selectin, and P-selectin
function in the early steps of neutrophil and eosinophil binding to the endothelium
before migration (Lawrence & Springer, 1991; Vadas et al., 1993).
There are a number of steps involved in recruitment of white blood cells into
the tissue depending on the inflammatory response. The general steps remain similar
between cell types, however the specific adhesion molecules involved differ in
expression and timing. The following paragraphs describe the migration of neutrophils
out of the vasculature generally observed in acute inflammation such as the wheal and
flare response of the skin when exposed to an antigen; and the migration of eosinophils
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generally observed in chronic inflammation such as atopic dermatitis (Malech & Gallin,
1987; Weller, 1991).
In neutrophil migration, the vascular endothelium is first activated by a
cytokine such as, TNF-alpha, IFN-gamma, or one of a number of interleukins (Pober
et al., 1989).

This activation causes up regulation of the selectins and the

immunoglobulin gene superfamily adhesion molecules (Bevilacqua et al., 1987;
Wegner et al., 1990). The neutrophil binds to the selectins using its Sialyated Lewis X
sugars. This is a loose association, causing the neutrophil to roll along the vascular
wall. Activation of the neutrophil by endothelial derived cytokines enables it to bind to
up regulated ICAM-1 via LFA-1. This firm binding is followed by the migration of the
neutrophil between the endothelial cells into the tissue (Ebisawa, 1992).
Eosinophil migration across the vascular endothelium is similar to neutrophil
migration in that the endothelium is first activated by cytokines, causing up regulation
of the selectins and the immunoglobulin gene superfamily adhesion molecules
(Bevilacqua et al, 1987). The eosinophils are first bound to the selectins via their
Sailylated Lewis X sugars (Vadas et al., 1993). They then bind more firmly using the
VLA-4NCAM-l binding set (Walsh et al., 1991). Once bound firmly, the eosinophil
migrates between endothelial cells into the tissue (Lamas et al., 1988).
Just as the role of cytokines and inflammatory mediators are being described in
the adhesion of eosinophils to endothelium, other substances such as hormones are
being studied to observe their effects on adhesion molecule expression. For example,
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estrogens may have the ability to alter adhesion molecule expression. This altered
expression may be important in determining how eosinophils enter the uterus in many
female mammals during the estrus stage of the estrous cycle. Alterations in endothelial
adhesion molecules via estradiol have been observed in certain endothelium-dependent
responses (Gisclard et al., 1988). Estradiol has been shown to up regulate expression
ofICAM-1, VCAM-1, and E-selectin in bovine aortic endothelial cells pretreated with
TNFa (Cid et al. 1994).

This up regulation increased the adhesion of poly

morphonuclear cells to the endothelium (Cid et al., 1994).

However, different

endothelial types react differently under the influence of estrogen and therefore
extrapolation of this relationship to uterine endothelium should be guarded.
Hormone Fluctuations During the Female Reproductive Cycle
Two critical events in the sexual cycle of mammals are the development of the
ovarian follicle to a mature egg and the preparation of the uterus for implantation of
the fertilized egg. During the follicular phase of the cycle, the hypothalamus releases
gonadotropin releasing hormone (GnRH). This in turn causes the anterior pituitary to
release follicle stimulating hormone (FSH) and leutinizing hormone (LH).

These

hormones promote follicular development in the ovary, which in turn secretes low
levels of estradiol. This low level of estradiol stimulates the uterus and other sexual
organs. As the follicle develops its estrogen secretion increases. Peak blood estrogen
levels have a stimulatory effect on the hypothalamus and the anterior pituitary causing
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an LH/FSH surge, leading to ovulation.

During the luteal phase the remammg

follicular cells transform to luteal cells which synthesize and secrete moderate levels of
estrogen and large amounts of progesterone.

These two hormones coordinate

preparation of the uterus for implantation (Hadley, 1992).
The LH and FSH released by the anterior pituitary indirectly cause cyclical
changes in the uterus from the resulting estrogen and progesterone levels. During the
proestrus phase, when FSH and LH levels rise, estrogen is also increased leading to
the LH surge. During this phase, the endometrial glands begin to increase in number
and length, the endometrial arterioles lengthen, and glycogen accumulates in the gland
basal epithelia. In the estrous stage of the cycle, endometrial glands increase further in
number, glycogen accumulates throughout the gland cells, the gland cells begin to
hypertrophy and there is stromal edema. Increase in vascularization within the uterus
enables the blood supply to extend further into the endometrium. During proestrus in
the rat there is an influx of eosinophils into and throughout the uterine body. This
influx continues throughout estrus, and then diminishes in diestrus (Rytomaa, 1960).
In diestrus the degeneration of the corpus luteum leads to the contraction of spiral
arteries decreasing the blood flow to the endometrium. This ischemia causes the
degeneration of the luminal endometruim, and the decrease in size of both the
endometrium and myometrium (Hadley, 1992)
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Specific Uterine Responses to Estrogens
The rat uterus responds to estrogen in various ways. These responses can be
divided into 3 different categories: genomic, non-genomic, and "other" (Jensen &
Desombre, 1972; Grunert & Tchernitchin, 1982). The genomic responses are a direct
result of estrogens effects on gene transcription, while the non-genomic responses are
due mainly to the actions of infiltrating eosinophils.

Genomic responses include

increases in uterine RNA and protein synthesis, increases in uterine enzyme
concentrations, and functional differentiation of target cells (Jensen & Desombre,
1972). The non-genomic responses are uterine eosinophilia, edema, increased vascular
permeablility, and histamine release (Tchernitchin, 1972). The "other" effects include
the increase in glycogen content via adenyl cyclase activation (Singha! et al., 1972). It
is possible to separate nongenomic and genomic responses to estrogen. Compounds
such as actinomycin D and puromycin inhibit RNA and protein synthesis, blocking
only the responses defined as genomic (Tchernitchin & Galand, 1987). Cochicine,
which blocks eosinophil migration by disrupting microtubule formation has been
shown to block the nongenomic responses to estrogen in the rat uterus (Soto &
Tchernitchin, 1979).
The possibility of the uterine vasculature having high affinity receptors for
estrogens has also been studied. Tchernitchin & Tchernitchin (1976), using autoradio
graphy showed evidence that high affinity estradiol receptors were present on the inner
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surface of small uterine blood vessels of immature rats. There is also evidence to
support the possibility that bovine aortic endothelial cells have receptors for estrogen
(Colburn & Buonassisi, 1978).
Eosinophils and Estrogen Receptors
Generally eosinophil migration is observed in chronically inflamed tissues
(Weller, 1991), but not in acute inflammation. The migration of eosinophils into the
uterus is very different. Eosinophils in this situation migrate into the uterus quickly.
This infiltration of eosinophils occur concomitantly with characteristic indicators of
acute inflammation such as edema, increased vascular permeability, and histamine
release (Tchernitchin et al., 1976).
Rytomaa (1960) and Bjersing & Borglin (1963) measured the fluctuation of
eosinophils into rat the uterus at the different stages of the estrous cycle. The number
of eosinophils per 0.1 sq. mm. reached its highest level at estrus (105) and its lowest
level during diestrus (2). This magnitude of eosinophil migration is unique to rats.
There have been several studies exploring the migration of eosinophils into the
rat uterus under the influence of estrogen. Tchernitchin et al. (1974) used immature
Wistar rats that had not yet begun to produce high levels of estrogen and injected them
interveinously with estradiol. The number of eosinophils in the whole uterus increased
from 90 to 150,000 in twenty-four hours. The population of eosinophils was always
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more within the endometrium as compared with the myometrium (Bjersing & Borglin,
1963).
The specific action that eosinophils have once they enter the uterus is not
known, however eosinophils are thought to be involved in restructuring of the uterus
as well as the protection of the blastocyst (Tchernitchin et al., 1989). Eosinophil
enzymes; P-glucuronidase, arylsulfatase, and collagenase have been reported to
depolymerase uterine extracellular matrix glycosaminoglycans and collagen fibers
(Tchernitchin et al., 1985). Protection of the blastocyst may be accomplished by
eosinophil phospholipase D which inactivates PAF, and EPO which decreases the
bioactivity of LTC4 and LTD4 (Tchernitchin et al., 1985).

EPO is also able to

inactivate heparin released by mast cells within the uterus (Tchernitchin et al., 1985).
Other eosinophil granule proteins and enzymes may further prepare the uterus and
protect the blastocyst (Tchernitchin et al., 1989).
Estrogen induced cell migration into the rat uterus is selective for eosinophils.
The mechanism for this unique migration has been postulated as follows; eosinophils
and/or the uterine vascular endothelium are activated by estrogen via their estrogen
receptors. The activation of these two cell types cause a change in them leading to
migration of the eosinophil, allowing it to elicit its effects on the uterus (Tchernitchin
& Tchernitchin, 1976).
Since the discovery that eosinophils migrate into the uterus under the influence
of estrogen there have been many studies to determine if eosinophils have a receptor
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for estrogen.

There have been several procedures applied to demonstrate the

localization of this receptor on eosinophils; wet radioautography (Tchernitchin, 1967),
dry radioautography in vivo (Tchernitchin et al., 1978) and, dry radioautography in
vitro (Tchernitchin et al., 1974). Lyttle et al. (1984) used radioactive estrogens and

Scatchard analysis to identify a specific estrogen receptor present in the uterus only
when eosinophils were in the uterus.

Lyttle identified two different estrogen

receptors, type I and type II. Isolated peritoneal eosinophils had an estrogen receptor
with a lower affinity (type 11), while a higher affinity receptor (type I) was located in
the uterus.

When eosinophils had infiltrated the uterus after estrogen injection

Scatchard analysis revealed two different estrogen receptors.

Tchernitchin &

Tchernitchin (1976) did similar Scatchard analysis resulting in a Kd of 5.6 x 10- 10 M
for the eosinophil estrogen receptor.
Selective migration of eosinophils is also observed in allergic reactions and
asthma. In asthma there is a unique increase of VCAM-1 expression on the lungs'
vascular endothelium, with no increase in ICAM-1 expression (Nakajima et al., 1994).
IL-4, which is typically released by T-cells in allergic responses interacts with the
surrounding endothelium causing a unique up regulation of VCAM-1 and down
regulation of ICAM-1 (Thornhill & Haskard, 1990). The binding of VLA-4 on the
eosinophil with its ligand VCAM-1 on the vasculature, may be an integral association
needed for eosinophil migration into the uterus under the control of estrogen. In this
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study we looked at the possible association between ICAM-1 and VLA-4 expression,
and estrogen induced migration of eosinophils into the uterus.

MATERIALS AND METHODS
Preliminary Study: Eosinophil Cycling in the August Rat Uterus
Due to its inherent peritoneal eosinophilia, the August rat was chosen for this
study. A preliminary study was undertaken to determine if these rats responded
similarly to other rat strains (i.e. Sprague Dawley and Wistar rats) in terms of
eosinophil cycling into the uterus throughout the stages of estrus.
Animals and Treatment
Mature female inbred August rats (Harlan Olac, UK) were used in all the
preliminary studies. Vaginal smears were obtained daily from each animal to ascertain
the status of their estrous cycle. The stage of estrus was determined by the criteria
stated by Ross & Klebanoff (1966). At a predetermined stage of estrus each animal
was euthanized by carbon dioxide asphyxiation.
Removal, Fixation, and Preparation of Uterine Tissue
The uterii were dissected out of six rats (2 from the proestrous stage, 2 from
the estrous stage, and 2 from the diestrous stage) and placed in 10% normal buffered
formalin. All uterine tissue in the preliminary, as well as the subsequent studies, under
went the following procedures in preparation for light microscopy. After fixation the
17
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tissue was dehydrated in a graded ethanol senes (70%-100%) followed by the
transition solvent, xylene, and embedded in paraffin (Tissue-Tek, Fisher Scientific).
The samples were then sectioned at 5 microns on a Reichert-Jung Biocut 2030
microtome and stained with Luna's, or Gills hematoxylin and eosin. The sections were
viewed using a Nikon Microphot FXA microscope and photographed with Kodak
160T film.
Eosinophil Quantification
In both preliminary and subsequent studies uterine eosinophils were counted in
60 non-overlapping fields of view, covering the length of the uterine horn. These
fields of view included 20 observations in the two layers of myometrium, 20 in the
lower portion of the endometrium and 20 in the upper portion of the endometrium
The field of view was set at 30 µm2 using Image-I®, image analysis software. The
endometrium was separated into upper and lower portions due to its non-uniform
eosinophil densities.
Estrogen Induced Eosinophil Migration into the August Rat Uterus
Immature female August rats injected with DES were used in this study to
determine the association between ICAM-1 and VLA-4 expression, and eosinophil
migration into the rat uterus.
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Animals and Treatment
Inbred female August rats (Harlan-Olac, UK), were used in this study. These
rats were 27 days old, and weighed 40-50 grams. Each rat was treated and then
placed back with its mother until euthanasia.
On the day of the experiment, the rats were divided into two groups of four
animals; control and experimental animals. The control animals were injected with the
vehicle, 0.1 ml of 10% ethanol in saline. The experimental animals were injected with
0.1 ml of a 200 µg /ml DES solution. DES (Sigma, St. Louis, MO) was dissolved in
I 0% ethanol and brought to 200 µg/ml with saline. DES was chosen due to its water
solubility and increased estrogen efficacy. The dose of DES was selected because it
increases blood "estrogen" levels to at least as high as they are during proestrus in the
rat. The diameter of the uterine horns, the height of the uterine epithelial lining of the
lumen, and the infiltration of eosinophils were measured to assess the estrogenic
, response. All dosing was accomplished with a single subcutaneous injection in the
subscapular region. All animals were euthanized via carbon dioxide asphyxiation 24
hours after the injections. The twenty-four hour time point was selected due to peak
eosinophilia and ICAM-1 expression in the uterus at this time.
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Removal and Fixation of Uterine Tissue
After asphyxiation the abdominal wall was cut exposing the uterii.

Both

uterine horns were excised at the cervix. One uterine horn from each animal was fixed
in an aqueous 10% neutral buffered formalin solution in preparation for light
°

microscopic analysis. The other horn was snap frozen in isobutanol at -160 C (cooled
by liquid nitrogen) and stored at -70 ° C in preparation for immunohistochemical
analysis.

Immunocytochemistry determining ICAM-1 and VLA-4 expression was

measured using monoclonal antibodies.
Immunohistochemical Analysis
For both ICAM-1 and VLA-4 studies, 8-12 frozen sagittal uterine sections
were cut from each of the 8 rats. Each uterus was cryosectioned at 6 µm in thickness
with a Tissue-Tek 4553 cryostat-microtome and placed on Poly-Lysine coated slides.
These slides were then fixed with cold acetone (4°C) for 10 minutes and air dried.
Indirect staining was conducted with a mouse IgG alkaline-phosphatase-ABC kit
(Vector Labs Inc., Burlingame, CA) following the manufacturers instructions. Briefly,
tissues were incubated with normal horse serum (blocking serum) to decrease non
specific staining. Primary, and secondary antibodies were diluted with 10 mM Tris
buffer, pH 7.5, containing 5% horse IgG (500 µg/ml)(Sigma ImmunoChemicals, St.
Louis, MO) to additionally reduce non-specific background. Sections were then
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incubated with primary antibody for 30 minutes at room temperature using either
monoclonal anti-rat ICAM-1 (provided by T. Manning, The UpJohn Co., Kalamazoo,
MI) at 1.56 µg/ml in 2% BSA-Trisma buffer, or monoclonal anti-rat VLA-4
(provided by T. Manning, The UpJohn Co., Kalamazoo, MI) at 275 µg/ml in 2%
BSA-Trisma buffer. After 10 dip and blot rinses with 10% ethanol-Tris buffer (pH
7.5) on an aqueous blotting pad, sections were incubated with a secondary antibody,
biotinylated horse anti-mouse IgG (1.25 ug/ml)(Vector Laboratories Inc., Burlingame,
CA) for 30 minutes and rinsed again.

The enzyme, alkaline phosphatase, was

incubated on the sections for 60 minutes followed by another Tris buffer rinse. Finally,
sections were incubated with the substrate, aminoethyl carbazole containing
levamisole, for 30 minutes and rinsed with distilled water.

The sections were

counterstained with Mayer's hematoxylin for 3 minutes and rinsed with tap water.
After staining, the slides were mounted and coverslipped using an aqueous mounting
medium.
Specific antibody binding was determined by comparing the antibody labeled
sections with a negative control section.

In the negative controls, the primary

antibodies were replaced with non-immune mouse IgG's at the same protein
concentration. To assure uniform staining, all tissue sections for each antibody studied
were labeled at one time.
ICAM-1 staining intensity was classified according to the criteria as described
by Briscoe et al. (1992) and Nakajima et al. (1994). The evaluation of ICAM-1
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expression on the endothelium was scored as 0 (absent staining or faint staining of an
occasional vessel only), 1 + (faint staining of several vessels), 2+ (moderate intensity
staining of most vessels), or 3+ (intense staining of most vessels). The sections were
randomly coded, examined, and the average section score for each animal was used for
subsequent calculation of ICAM-1 expression. The DES-treated animals exposed to
the VLA-4 antibody labeling system were compared to normal August rat blood
eosinophils, because there are very few eosinophils within the immature control uterii.
Fifty eosinophils from the blood were identified and scored, uterine and blood
eosinophils were evaluated using the same intensity classification used in the ICAM-1
evaluation.
Eosinophils from the cryosections were identified by their high nuclear to
cytoplasm ratio, location in the uterus, as well as density within the uterus. Density
and location criteria was determined by the eosinophils present in hematoxylin and
eosin stained DES treated uterine sections.

Eosinophils in the blood slides were

identified by their nuclear to cytoplasm ratio, their size, and their donut shaped
nucleus.
Data Analysis
Data are presented as mean + / - SEM. All statistical analyses were performed
by a Student-T-test using Quattro Pro®. An value of 0.05 was used to determine
significance.

RESULTS
General Observations
The preliminary study showed the August rat uterine changes during estrus;
this included uterine weight and size changes, as well as the influx of eosinophils. All
three criteria increased from proestrus through estrus and thereafter decreased in
metestrus.
Twenty-four hours after a subcutaneous injection, DES induced. morpho
logical changes in the immature rat uterus included edema, increased vascularization,
increased epithelial height, and the influx of eosinophils.
Morphological Evaluation
Control Rats
Each uterine horn of the control immature August rats had a diameter of
approximately 1 mm. Upon examining sagittal sections of the uterii it was noted that
the tissue was not edematous and had little vascularization. The three major layers of
the uterus; the endometrium and the two myometrial layers, were easily distinguishable
as seen in Figure 1. The glands were small with a simple cuboidal epithelium. The
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epithelium lining the uterine lumen was composed of simple and cuboidal cells, as see
in Figure 2.
DES Treated Rats
The uterine horns of DES treated rats were markedly different from those of
control animals. Upon gross examination the vasculature was more easily seen and the
diameter of the uterine horns had increased to over twice that observed in controls, as
seen in Figure 3. Longitudinal sections of the treated rat uterus revealed a much more
vascularized uterus which was highly edematous, as seen in Figure 4. The uterine
glands were more twisted with columnar epithelial cells and the height of the epithelial
lining of the uterus was approximately three times greater, as seen in Figures 5 and 6.
The uterus also was infiltrated with eosinophils as seen in Figures 7 and 8. A high
density of eosinophils was evident near the endometrial/myometrial border.
Immunohistological Staining
General Observations
Immunostaining of the immature control uterine sections for ICAM-1 ex
pression resulted in intense staining of the uterine vasculature. However, there was
substantially less labeling on immature DES treated rat uterine sections as compared to
the control rat uterine sections. VLA-4 expression on the eosinophils within the
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Figure 1.

Photomicrograph of a Cross Section of Uterine Horn From an
Untreated Rat. (x 100)
In this micrograph, observe the myometrial layers (M) and the
endometrial layer (E) with its epithelium. Also observe the
compactness of the uterine tissue with no fluid accumulation.

26

Figure 2.

Photomicrograph of the Epithelial Lining From the Uterine Horn of an
Untreated Rat. (x 1000)
In this micrograph, observe the cuboidal epithelial cells (Ep) lining the
luminal side of the horn.
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Figure 3.

Treated

Comparison of Uterine Diameter Between Control and DES Treated
Rats.
There were 3 animals in each group. Each uterus was cross sectioned
and 4 random positions along the uterine horn were measured using
Image-I® software. Significant at p � 0. 05 by Student-T-test.
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Figure 4.

Photomicrograph of a Sagittal Section of the Uterine Horn From a
DES Treated Rat. (x 100)
In this micrograph, observe the myometrial layers (M) and the
endometrial layer (E) with its epithelial luminal covering. Also observe
the edema in the submucosa.
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Figu re 5.

Photomicrograph of the Epithelial Lining in a DES Treated Uterine
Horn. (x 1000)
In this micrograph, observe the tall columnar epithelial cells (Ep) lining
the luminal side of the uterine horn.
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Figure 6.

Treated

Comparison of the Epithelial Cell Height Between the Control and
DES Treated Groups.
10 height measurements were made for each animal. There were 4
animals in each group. The animals in the treated group were
injected subcutaneously with 20 µg of DES. Significant at p � 0.05 by
Student-T-test.
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Figure 7.

Photomicrograph ofEosinophils Within the Uterus of the DES Treated
Rat. (x 1000)
In this micrograph, observe an eosinophil (E) with the intense coloring
of its "donut" shaped nucleus. This eosinophil is located in the lower
portion endometrium where a high concentration of these cells are
found.
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Endometrium Epithelium

Comparison of the Concentration of Uterine Eosinophils Within the
Myometrium, Basement Endometrium, and the Upper Endometrium.
of the DES Treated Rat.
20 fields were measured in each tissue layer for each animal. There
were 4 animals in this group which were injected subcutaneously with
20 µg of DES 24 hours before uterine harvest.
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vasculature and interstitial tissues of the uterus had a higher intensity than normal
blood eosinophils.
ICAM-1 Uterine Staining.
There was an observable difference between the control tissue and the treated
tissues response to the monoclonal antibody against ICAM-1. In Figure 9, a section of
an untreated uterine horn is stained by the product of the enzyme alkaline phosphatase
which was coupled to IgG directed against ICAM-1. Figure 9 shows the labeling of
the endothelial cells in the control uterine vasculature. Figure 10 shows the labeling of
the endothelial cells of the uterine vasculature in the DES treated uterus. The staining
is much lighter in the treated uterus, indicating a decrease in labeling for ICAM-1.
When the tissue sections were scored using the criteria defined by Briscoe (1992)
there was a significant difference between the DES treated uterii and the control uterii,
as seen in Figure 11.
VLA-4 Uterine Eosinophil Staining
When the control uterine tissues were examined for VLA-4 there was only
background staining of the untreated tissue and no eosinophils were observed,
however there was a substantial amount of intensely stained eosinophils in the DES
treated uterii. Examples of this staining can be seen in Figure 12 and 13. The criteria
used to identify the eosinophils is described in the Material and Methods section. The
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uterine eosinophils were intensely stained indicating the presence of VLA-4 on these
eosinophils. Using the criteria described by Briscoe et al. ( 1992), the eosinophils in
the uterus of the DES treated rats were compared to blood eosinophils in controls.
The scores for uterine eosinophils were consistently higher than those of the blood in
untreated rats. The increase in labeling intensity on the eosinophils in the uterus is
seen in Figure 12, as compared with the blood eosinophils shown in Figure 14. This
suggests an increase of VLA-4 on eosinophils within the uterus and uterine
vasculature.
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Figure 9.

Photomicrograph of the Staining of the Untreated Uterus With a
Monoclonal Antibody Against ICAM-1. (x 1000)
In this micrograph, observe the endothelial cells which are staining
for an antibody against ICAM-1. Also observe the rest of the section
which is not stained, indicating no ICAM-1 expression.
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Figure 10.

Photomicrograph of a DES Treated Uterus Stained With a
Monoclonal Antibody Against ICAM-1. (x 1000)
In this micrograph, observe the endothelial cells which are lightly
staining for ICAM-1. Also observe the rest of the section which is not
stained, indicating no ICAM-1 expression.
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Figure 11.

Treated

Estrogen Induced ICAM-1 Expression on the Endothelium of Rat
Uterii 24 Hours After a Subcutaneous Injection of DES.
The intensity of staining was scored according to the following
criteria; 0 = absent staining or faint staining of an occasional vessel
only, 1 = faint staining of several vessels, 2 = moderate intensity
staining of most vessels, and 3 = intense staining of most vessels.
Significant at p � 0.05 by Student-I-test.
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Figure 12.

Photomicrograph of the DES Treated Uterus Stained With a
Monoclonal Antibody Against VLA-4. (x 1000)
In this micrograph, observe the eosinophil which is staining
for an antibody against VLA-4. Also observe the remainder of the
section which is not stained indicating no VLA-4 expression.
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Figure 13.
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Photomicrograph of the DES Treated Uterus Stained With a
Monoclonal Antibody Against VLA-4. (x 1000)
In this micrograph, observe the eosinophil (E) which is in the
vasculature stained with an antibody against VLA-4. Also observe the
adjacent cell of the section which is also stained. Because of its size
and expression ofVLA-4, it is probably a T-lymphocyte.
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L

Figure 14.

•

Photomicrograph of the Staining of a Control Blood Sample Including
Eosinophils With a Monoclonal Antibody Against VLA-4. (x 1000)
In this micrograph, observe the eosinophil (E) which is staining
for an antibody against VLA-4. Also observe the rest of the section
which contains a lymphocytes (L) staining for VLA-4.

DISCUSSION
The purpose of this study was to determine the association between
intercellular adhesion molecule expression and eosinophil recruitment into the rat
uterus in response to DES. We hypothesized that the contributory adhesion molecule
expression pattern would be similar to that seen in an eosinophilic selective response,
such as asthma. The typical response in asthma is an increase in the expression of
VCAM-1 (the ligand for VLA-4) with no increase in ICAM-1 or its ligand LFA-1
(Nakajima et al., 1994). The up regulation of VCAM-1 may cause a selective increase
in extravasation of eosinophils into the lungs because other leukocytes, such as
neutrophils, do not possess the ligand for VCAM-1 and therefore may not as readily
migrate. Increasing evidence from in vitro models indicates that induced eosinophilia
is associated with an increase in expression of VCAM-1 while there is no substantial
increase in ICAM-1 expression (Thornhill & Haskard, 1991). In other studies
monoclonal antibodies to VCAM-1 or VLA-4 cause a 75% decrease in eosinophil
adherence to endothelium (Schleimer et al., 1992), while the remaining adherence was
demonstrated to be caused by ICAM-1 (near total blocking of adherence was
demonstrated when monoclonal antibodies to both ICAM-1 and VCAM-1 were
administered). The importance of ICAM-1 in this instance may be over estimated
since subjects with LADS (leukocyte adhesion deficiency syndrome), which destroys
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LFA-1 's ability to bind to ICAM-1, still have eosinophils in extravascular sites of
inflammation (Anderson et al., 1987). This ICAM-1 adhesion may be a type of
nonspecific binding for all leukocytes which does not necessarily lead to immigration
into the tissues (Weller, 1991).
One of the underlying signals for specific eosinophil infiltration with allergic
reactions seem to be IL-4 (Thornhill & Haskard, 1991). IL-4 is an inflammatory
mediator which specifically enhances eosinqphil adherence and migration through
endothelial cell layers (Moser et al., 1992b).

The enhanced adherence and

extravasation of the eosinophil across the endothelial layer is postulated to be due to
the ability of IL-4 to specifically up regulate VCAM-1 (Thornhill & Haskard, 1990).
IL-4 has also been shown to partially suppress constitutive expression ofICAM-1 on
the endothelium. (Thornhill & Haskard, 1990). In our study we observed an up
regulation of the ligand for VCAM-1, VLA-4.
In this study DES was administered 24 hours before the uterine horns were
removed for examination. The typical effects of estrogen were observed in the uterus
including; increased vascularization, edema, epithelial proliferation, and eosinophil
migration. Immunohistochemical analysis demonstrated a decrease in the constitutive
expression ofICAM-1 on the uterine vasculature as well as an increased expression of
VLA-4 on uterine eosinophils as compared to control blood eosinophils. Since there
is no available rat monoclonal antibody to VCAM-1 it was not possible to study the
presence of this molecule in this study.

However ICAM-1 and VLA-4 findings
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suggest a similarity between eosinophil migration m a true, eosinophil selective,
inflammatory response and in an inflammatory "like" response.

The decrease in

ICAM-1 expression on uterine vasculature suggest that ICAM-1 and its ligand LFA-1
are not important in this eosinophil migration.

The up regulation, or at least

expression, of VLA-4 on uterine eosinophils allows us to speculate that VLA-4/
VCAM-1 binding may be involved in selective eosinophil migration into the uterus.
Adhesion molecule expression was measured in this study, not function, therefore we
can only speculate how this expression may relate to function.
The majority of VLA-4 research has focused on blocking assays and assays
using human in vitro models. Our research is unique because we used a rat model in
which we labeled VLA-4 in situ. This is important because it is a labeling experiment,
not a blocking experiment, that is specific for localizing VLA-4. It also demonstrates
that VLA-4 is present on the August rat eosinophils. This confirms that eosinophils in
this rat are similar to human eosinophils in their VLA-4 expression. This similarity
could allow for the important switch from research emphasis on in vitro, to the more
realistic setting of in vivo models without necessitating the use of primates.
At this time it is difficult to determine if eosinophils are activated without using
electron microscopy.

It would be interesting to observe VLA-4 expression on

eosinophils in different inflammatory events. It is possible that up regulation of VLA4 could be an indicator of eosinophil activation.
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The exact mechanism for the up regulation of VCAM-1 and down regulation
ofICAM-1 during eosinophil migration have not been elucidated. Tchernitchin (1976)
suggested that vascular endothelial cells in the uterus have receptors for estrogen, and
Colburn & Buonassisi (1978) presented evidence to support this supposition in bovine
aortic endothelial cells. Tchernitchin and coworkers also reported in a series of papers
between 1967 and 1978 that eosinophils have specific estrogen receptors. These
receptors unlike uterine estrogen receptors were always available, not fluctuating in
number under hormone control (Tchernitchin, 1976). It is possible that estrogen binds
to eosinophils, up regulating or activating VLA-4. Estrogen may also interact with
uterine vascular endothelium, causing up regulation of selectins and VCAM-1,
enabling selective eosinophil binding and migration into the uterus.
Looking further beyond the scope of this study, the rapidity of eosinophil
migration into the uterus is difficult to explain. Tchernitchin et al. (1972) observed a
rapid influx of eosinophils into the uterus after an IV injection of estrogen. Because of
the time frame required for up regulation, adhesion molecules which require protein
synthesis cannot account for this migration.
This suggests several possibilities: First, P-selectin (GMP-140) may be released
from Weibel-Palade bodies, rapidly translocating to the surface of the uterine
endothelium due to estrogen stimulation. This is seen in endothelial cell cultures with
histamine activation (Hattori et al., 1988). The process of increasing cell surface P
selectin seems to be by means of translocation of Weibel-Palade Body vesicles fusing
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with the endothelial plasma membrane.

Eosinophils bind to P-selectin on the

endothelium (Vadas et al., 1993). P-selectin is specifically mentioned because of its
unique ability to translocate rapidly, peaking 10 minutes after stimulation with
histamine (Hottori et al., 1988). Secondly, down regulation ofICAM-1 may alter the
eosinophils' ability to bind to endothelial cells, somehow allowing it more direct access
to VCAM-1. This possibility is unlikely since the kinetics ofICAM-1 down regulation
is in terms of hours, not minutes (Thornhill & Haskard, 1991). Thirdly, the presence
of estrogen may alter the conformation of VLA-4 which in itself allows VLA-4 and
VCAM-1 to bind to one another more efficiently. This "activation" of cell adhesion
molecules has been seen with Mac-1, LFA-1 and VLA-4 under the control of different
cytokines (Chatila et al., 1989; Springer, 1990). It is suspected that this activation
may result from the phosphorylation of these molecules. Chatila et al. (1989) used a
protein kinase C activator, which in turn phosphorylated the CD18 residue of the
CDll/18 heterodimer. This phosphorylation caused a conformational change in the
complex, increasing its binding ability. Obviously these options do not have to act
exclusively, and possibly a combination of one with another could explain this rapid
migration.
Because of the rapidity of eosinophil migration into the rat uterus and the
unique expeditious expression of P-selectin on endothelial cells after histamine
stimulation, it would be interesting to block P-selectin and observe what affects it may
have on eosinophil migration into the uterus. It would also be interesting to examine
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the VLA-4 molecule on both resting and estrogen "activated" eosinophils in vitro to
determine if there are different degrees of phosphorylation.

CONCLUSION
The results of this study support the findings in other models involving
selective eosinophil recruitment out of the vasculature, ·such as asthma. The presence
of adhesion molecules specific to eosinophils (not neutrophils) such as VLA-4 have
been observed in other studies. August rat eosinophils were shown to express VLA-4
in this study.

We noted a decrease in ICAM-1 expression from its constitutive

expression on the vasculature. This is similar to studies where IL-4 was shown to also
down regulate ICAM-1 in a model of eosinophil recruitment.
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